Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: Annu Rev Pathol. 2009;4:199–227. doi: 10.1146/annurev.pathol.4.110807.092222

Table 1. miRNome analyses in cancers.

miRNA expression profiles from clinical specimens or cancer cell lines are listed according to tumor types. Profiling methods are bead based flow cytometric profiling (bead), qRT-PCR, microarray of miRNA chip (array), membrane spotted array (membrane), cloning, or miSAGE (serial analysis of gene expression of miRNA). miRNAs of notable change are indicated

Tumor type Profiling
method
miRNAs deregulated in tumor note ref
up-regulated down-regulated
breast cancer bead classification of breast
tumors into five sub-types
(93)
breast tumor qRT-PCR
array
miR-21 (165)
breast cancer array classification according to
ErbB2/ER status
(158)
breast cancer array miR-21 miR-125b, -145 clinicopathologic features (185)
prostate cancer array let-7c, miR-
125b, miR-145
(186)
prostate cancer membrane classification according to
androgen dependency
(66)
prostate cancer array (158)
pancreatic
cancer
array miR-21, -221, -222,
-181a, -181b, -
181d, -155
vs. chronic pancreatitis and
normal tissues
(187)
pancreatic
cancer
array miR-196a miR-217 pancreatic ductal
adenocarcinoma vs.
chronic pancreatitis and
normal tissues
(160)
pancreatic
cancer
qRT-PCR
of pre-
miRNA
let-7i, miR-100, -
155, -221, -301, -
21,-181a, -125b, -
212, -376a
miR-375 pancreatic
adenocarcinoma, paired
benign tissue, normal
pancreas, chronic
pancreatitis
(188)
pancreatic
tumor
array miR-103, -107, -
23a, -26b, -342, -
192, -204, -211, -21
miR-155 endocrine tumors vs.
acinar cell carcinoma
(189)
lung cancer array miR-21, -205 miR-126* clinicopathological
features
(190)
ovarian cancer array miR-200a, -141 miR-199a, -140,
-145, -125b1
clinicopathological
features
(191)
cervical cancer array vs. Drosha overexpression (95)
uterine
leiomyoma
array let-7, miR-21, -23b clinicopathological
features (tumor size, race,
etc)
(192)
hepatocellular
cancer
array miR-21 (134)
hepatocellular
cancer
array miR-221 let-7a, miR-122a vs. liver cirrhosis (193)
hepatocellular
cancer
array miR-224, -18 miR-199a, -
199a*, -200a
(194)
thyroid cancer array miR-30d, -125b,
-26a, and -30a-
5p
anaplastic thyroid
carcinomas vs. normal
tissues
(67)
thyroid cancer array miR-197, -346 in
FTC relative to FA
follicular thyroid
carcinoma (FTC) vs.
follicular adenoma (FA)
(195)
thyroid cancer array miR-221, -222, -
181b
papillary thyroid
carcinoma vs. normal
tissues
(159)
thyroid cancer array miR-221, -222, -
146b
papillary thyroid
carcinoma vs. normal
tissues
(100)
colorectal
cancer
array miR-25, -92 in
MSS relative to
MSI-H
microsatellite stability
(MSS) vs. high
microsatellite instability
(MSI-H)
(196)
colorectal
cancer
qRT-PCR miR-31, -96, -135b,
-183
miR-133b, -145 miR-31 according to
cancer stage
(197)
colorectal
cancer
cloning
miSAGE
(17)
pituitary
adenomas
array miR-26a, -149 miR-21, -141, -
144
clinicopathological
features
(198)
neuroblastoma qRT-PCR neuroblastoma subtypes (69)
glioblastoma array miR-221. -10b miR-128, -181b,
-181a
(199)
leukemia bead miR-128a, -128b in
ALL compared
with AML
let-7b, miR-223
in ALL
compared with
AML
acute lymphoblastic
leukemia (ALL) vs. acute
myeloid leukemia (AML)
(200)
leukemia cloning miR-21, -150, -155 miR-92, -222 various chronic
lymphocytic leukemias
(CLL)
(201)
leukemia array miR-29b, -181b
in aggressive
CLL with 11q
deletion
three subtypes of CLL (202)
leukemia array miR-16-1,-15a CLL according to ZAP-70
and IgVH
(203)
leukemia array B-cell CLL (65)
various tumors array
cloning
various sarcomas (204)
various tumors array solid tumors (lung, breast,
stomach, prostate, colon,
and pancreatic tumors)
(122)
various tumors bead comprehensive collection
of various cancers and
normal tissues
(64)